Two senators wrote to the FDA Friday about the Hims Super Bowl ad, which they said misleads patients about compounded weight ...

The spot “is a clear violation” of the FDCA, “which requires that advertising for prescription drugs — including compounded ...

While the Supreme Court's ruling was directed at the advertising restrictions in section 503A of the Federal Food, Drug, and Cosmetic Act, it had the effect of invalidating the entire section ...

The Partnership for Safe Medicines, a pharmaceutical industry group, is asking the U.S. FDA to “take action” against a “dangerous” ad that Hims ...

Zyn is a pouch containing nicotine powder that is intended to rest in a user's mouth while the stimulant is absorbed into their bloodstream. The FDA's authorization of Zyn marks the first time ...

The FDA's move has set a "dangerous precedent ... as less addictive than cigarettes and targeted minors with glamorous advertising campaigns. The company did not admit wrongdoing in the settlement.

False or misleading claims made in drug advertisements may harm persons who rely on those claims. Direct-to-consumer advertising of prescription drugs may result in inappropriate prescribing of ...